Do you want to read an article? Please log in or register.
IGF-1 and cardiometabolic diseases: a Mendelian randomisation study
Type 2 Diabetes
COMMENTED
Related content
Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery
Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study
JAMA Cardiol.
Lyall DM, Celis-Morales C, Ward J, Iliodromiti S, Anderson JJ, Gill JMR, Smith DJ, Ntuk UE, Mackay DF, Holmes MV, Sattar N, Pell JP
doi: 10.1001/
COMMENTED
Type 1 Diabetes
Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study
Diabetes Care.
Braffett BH, Dagogo-Jack S, Bebu I, Sivitz WI, Larkin M, Kolterman O, Lachin JM, DCCT/EDIC Research Group
doi: 10.2337/dc18-1574.
COMMENTED
Further Publications
Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
doi: 10.1007/s00125-020-05124-5.
COMMENTED
Diabetes - GeneralType 1 DiabetesThyroid
Incidence and Risk of Celiac Disease after Type 1 Diabetes: A Population-Based Cohort Study Using The Health Improvement Network Database
Pediatr Diabetes.
Vajravelu ME, Keren R, Weber DR, Verma R, De León DD, Denburg MR
doi: 10.1111/pedi.12770.
COMMENTED
Further Publications
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a doubleblind, randomised withdrawal phase
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol.
Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, Shimatsu A, Gu F, Auchus R, Leelawattana R, Lee EJ, Kim JH, Lacroix A, Laplanche A, O'Connell P, Tauchmanova L, Pedroncelli AM, Biller BMK, LINC 3 investigators
doi: 10.1016/S2213-8587(20)30240-0.
COMMENTED
Diabetic Complications
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
doi: 10.1016/S2213-8587(20)30026-7.
Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
Diabetologia.
Eriksson JW, Lundkvist P, Jansson PA, Johansson L, Kvarnström M, Moris L, Miliotis T, Forsberg GB, Risérus U, Lind L, Oscarsson J
doi: 10.1007/s00125-018-4675-2.
Type 1 Diabetes
Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 years in Adults With Type 1 Diabetes: The CACTI Study
Diabetes Care.
Bjornstad P, Wiromrat P, Johnson RJ, Sippl R, Cherney DZ, Wong R, Rewers MJ, Snell-Bergeon JK
doi: 10.2337/dc18-1527.
COMMENTED
Type 2 Diabetes
Is Type 2 Diabetes Mellitus Causally Associated with Cancer Risk? Evidence From a Two-Sample Mendelian Randomisation Study
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
doi: 10.2337/db20-0084.